Arrazuria Rakel, Ladero Iraia, Molina Elena, Fuertes Miguel, Juste Ramón, Fernández Miguel, Pérez Valentín, Garrido Joseba, Elguezabal Natalia
Animal Health Department, NEIKER-Instituto Vasco de Investigación y Desarrollo Agrario. Derio, E-48160 Bizkaia, Spain.
Department of Animal Health, Instituto de Ganadería de Montaña (CSIC-ULE), Facultad de Veterinaria, Universidad de León, E-24071 Leon, Spain.
Vet Sci. 2020 Jan 10;7(1):7. doi: 10.3390/vetsci7010007.
Paratuberculosis (PTB) is an enteric granulomatous disease caused by subsp. (MAP) that mainly affects ruminants. Current vaccines have shown to be cost-effective control reagents, although they are restricted due to cross-interference with bovine tuberculosis (bTB). Therefore, novel vaccination strategies are needed and this study is focused on evaluating alternative vaccination routes and their effect on the local immune response. The MAP oral challenge rabbit model was used to evaluate and compare an experimental inactivated MAP vaccine through oral (VOR) and intradermal (VID) routes. The VID group presented the highest proportion of animals with no visible lesions and the lowest proportion of animals with MAP positive tissues. Immunohistochemistry analysis revealed that the VID group presented a dominantly M1 polarized response indicating an ability to control MAP infection. In general, all vaccinated groups showed lower calprotectin levels compared to the non-vaccinated challenged group suggesting less active granulomatous lesions. The VID group showed some degree of skin test reactivity, whereas the same vaccine through oral administration was completely negative. These data show that PTB vaccination has an effect on macrophage polarization and that the route influences infection outcome and can also have an impact on bTB diagnosis. Future evaluation of new immunological products against mycobacterial diseases should consider assaying different vaccination routes.
副结核病(PTB)是一种由副结核分枝杆菌亚种(MAP)引起的肠道肉芽肿性疾病,主要影响反刍动物。目前的疫苗已被证明是具有成本效益的防控试剂,尽管由于与牛结核病(bTB)存在交叉干扰而受到限制。因此,需要新的疫苗接种策略,本研究聚焦于评估替代接种途径及其对局部免疫反应的影响。采用MAP口服攻毒兔模型,通过口服(VOR)和皮内(VID)途径评估和比较一种实验性灭活MAP疫苗。VID组中无可见病变的动物比例最高,MAP阳性组织的动物比例最低。免疫组织化学分析显示,VID组呈现出主要为M1极化的反应,表明其具有控制MAP感染的能力。总体而言,与未接种疫苗的攻毒组相比,所有接种疫苗的组中钙卫蛋白水平均较低,提示肉芽肿性病变活性较低。VID组表现出一定程度的皮肤试验反应性,而通过口服给药的同一疫苗则完全呈阴性。这些数据表明,PTB疫苗接种对巨噬细胞极化有影响,接种途径会影响感染结果,并且可能对bTB诊断产生影响。未来针对分枝杆菌疾病的新免疫产品评估应考虑检测不同的接种途径。